Open Access and Peer-reviewed
Home Journal Issues Guide for Authors Editorial Board Aims & Scope About Journal News & Announcements


Original Research 
RMJ. 2022; 47(3): 544-547


Relationship of GSTT1 and GSTM1 polymorphism in anti TB drug-induced hepatotoxicity

Syed Mehmood Qadir, Om Parkash, Pir Zada, Muhammad Haroon, Sham Lal, Rani Faryal.

Abstract
Objective: To investigate the association of Glutathione S-transferase theta-1 (GSTT1) and Glutathione S- transferase Mu 1 (GSTM1) polymorphism in antituberculosis drug induced hepatotoxicity.
Methodology: This case study was conducted at Department of Microbiology, Quaid-i-Azam University, Islamabad. We recruited 243 tuberculosis (TB) patients receiving anti-TB therapy using judgment sampling technique. They were classified as cases and controls. Out of 243 patients, 132 TB patients with ATDILI were used as cases while 111 TB patients were controls. Genetic polymorphism among cases and controls were determined using multiplex polymerase chain reactions.
Results: ATDILI was observed in 132 patients. Genetic analysis showed that the frequencies of GSTM1 and GSTT1 null hypothesis were not different in either cases or controls (p=0.9, p=0.8).
Conclusion: It can be inferred that GSTM1 and GSTT1null genotype may not be associated with hepatotoxicity in TB patient using antituberculosis therapy.

Key words: Anti-TB drug, GSTT1, GSTM1, hepatotoxicity, tuberculosis.


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Syed Mehmood Qadir
Articles by Om Parkash
Articles by Pir Zada
Articles by Muhammad Haroon
Articles by Sham Lal
Articles by Rani Faryal
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Qadir SM, Parkash O, Zada P, Haroon M, Lal S, Faryal R. Relationship of GSTT1 and GSTM1 polymorphism in anti TB drug-induced hepatotoxicity. RMJ. 2022; 47(3): 544-547.


Web Style

Qadir SM, Parkash O, Zada P, Haroon M, Lal S, Faryal R. Relationship of GSTT1 and GSTM1 polymorphism in anti TB drug-induced hepatotoxicity. https://www.rmj.org.pk/?mno=25323 [Access: September 02, 2022].


AMA (American Medical Association) Style

Qadir SM, Parkash O, Zada P, Haroon M, Lal S, Faryal R. Relationship of GSTT1 and GSTM1 polymorphism in anti TB drug-induced hepatotoxicity. RMJ. 2022; 47(3): 544-547.



Vancouver/ICMJE Style

Qadir SM, Parkash O, Zada P, Haroon M, Lal S, Faryal R. Relationship of GSTT1 and GSTM1 polymorphism in anti TB drug-induced hepatotoxicity. RMJ. (2022), [cited September 02, 2022]; 47(3): 544-547.



Harvard Style

Qadir, S. M., Parkash, . O., Zada, . P., Haroon, . M., Lal, . S. & Faryal, . R. (2022) Relationship of GSTT1 and GSTM1 polymorphism in anti TB drug-induced hepatotoxicity. RMJ, 47 (3), 544-547.



Turabian Style

Qadir, Syed Mehmood, Om Parkash, Pir Zada, Muhammad Haroon, Sham Lal, and Rani Faryal. 2022. Relationship of GSTT1 and GSTM1 polymorphism in anti TB drug-induced hepatotoxicity. Rawal Medical Journal, 47 (3), 544-547.



Chicago Style

Qadir, Syed Mehmood, Om Parkash, Pir Zada, Muhammad Haroon, Sham Lal, and Rani Faryal. "Relationship of GSTT1 and GSTM1 polymorphism in anti TB drug-induced hepatotoxicity." Rawal Medical Journal 47 (2022), 544-547.



MLA (The Modern Language Association) Style

Qadir, Syed Mehmood, Om Parkash, Pir Zada, Muhammad Haroon, Sham Lal, and Rani Faryal. "Relationship of GSTT1 and GSTM1 polymorphism in anti TB drug-induced hepatotoxicity." Rawal Medical Journal 47.3 (2022), 544-547. Print.



APA (American Psychological Association) Style

Qadir, S. M., Parkash, . O., Zada, . P., Haroon, . M., Lal, . S. & Faryal, . R. (2022) Relationship of GSTT1 and GSTM1 polymorphism in anti TB drug-induced hepatotoxicity. Rawal Medical Journal, 47 (3), 544-547.








AUTHOR LOGIN

REVIEWER LOGIN

Indexed
&
Abstracted


Indexed in WHO Index Medicus IMEMR, Emromedex, Pakmedinet, ExtraMED,  Scopus, Web of Science and Tehqeeqat

                     Approved by the Higher Education Commission of Pakistan 


ABOUT JOURNAL
POLICIES
STATEMENTS

This is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal without asking prior permission from the publisher or the author. This is in accordance with the Budapest Open Access Initiative (BOAI) definition of open access.

The articles in Rawal Medical Journal are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc-sa/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.